171 related articles for article (PubMed ID: 34685612)
1. Epigenetic DNA Modifications Upregulate SPRY2 in Human Colorectal Cancers.
Stuckel AJ; Zeng S; Lyu Z; Zhang W; Zhang X; Dougherty U; Mustafi R; Zhang Q; Joshi T; Bissonnette M; Choudhury SR; Khare S
Cells; 2021 Oct; 10(10):. PubMed ID: 34685612
[TBL] [Abstract][Full Text] [Related]
2. Hypoxia inducible factors regulate the transcription of the sprouty2 gene and expression of the sprouty2 protein.
Gao X; Hicks KC; Neumann P; Patel TB
PLoS One; 2017; 12(2):e0171616. PubMed ID: 28196140
[TBL] [Abstract][Full Text] [Related]
3. Aging related methylation influences the gene expression of key control genes in colorectal cancer and adenoma.
Galamb O; Kalmár A; Barták BK; Patai ÁV; Leiszter K; Péterfia B; Wichmann B; Valcz G; Veres G; Tulassay Z; Molnár B
World J Gastroenterol; 2016 Dec; 22(47):10325-10340. PubMed ID: 28058013
[TBL] [Abstract][Full Text] [Related]
4. DNA hypermethylation and decreased mRNA expression of MAL, PRIMA1, PTGDR and SFRP1 in colorectal adenoma and cancer.
Kalmár A; Péterfia B; Hollósi P; Galamb O; Spisák S; Wichmann B; Bodor A; Tóth K; Patai ÁV; Valcz G; Nagy ZB; Kubák V; Tulassay Z; Kovalszky I; Molnár B
BMC Cancer; 2015 Oct; 15():736. PubMed ID: 26482433
[TBL] [Abstract][Full Text] [Related]
5. Atypical role of sprouty in p21 dependent inhibition of cell proliferation in colorectal cancer.
Zhang Q; Shim K; Wright K; Jurkevich A; Khare S
Mol Carcinog; 2016 Sep; 55(9):1355-68. PubMed ID: 26293890
[TBL] [Abstract][Full Text] [Related]
6. Atypical role of sprouty in colorectal cancer: sprouty repression inhibits epithelial-mesenchymal transition.
Zhang Q; Wei T; Shim K; Wright K; Xu K; Palka-Hamblin HL; Jurkevich A; Khare S
Oncogene; 2016 Jun; 35(24):3151-62. PubMed ID: 26434583
[TBL] [Abstract][Full Text] [Related]
7. Dual role of sprouty2 as an inhibitor of RAS/ERK-driven proliferation and a promoter of cancer invasion in KRAS wild-type colorectal cancer.
Lee CT; Chu CA; Wang YM; Wang YW; Chen YL; Ho CL; Yeh YM; Lin PC; Lin BW; Chen PC; Chen SH; Chan RH; Chang C; Chow NH
Mol Carcinog; 2023 Jul; 62(7):951-962. PubMed ID: 37014154
[TBL] [Abstract][Full Text] [Related]
8. Sprouty4 is epigenetically upregulated in human colorectal cancer.
Stuckel AJ; Zeng S; Lyu Z; Zhang W; Zhang X; Dougherty U; Mustafi R; Khare T; Zhang Q; Joshi T; Bissonnette M; Khare S
Epigenetics; 2023 Dec; 18(1):2145068. PubMed ID: 36384366
[TBL] [Abstract][Full Text] [Related]
9. Promoter methylation and expression of SOCS-1 affect clinical outcome and epithelial-mesenchymal transition in colorectal cancer.
Kang XC; Chen ML; Yang F; Gao BQ; Yang QH; Zheng WW; Hao S
Biomed Pharmacother; 2016 May; 80():23-29. PubMed ID: 27133036
[TBL] [Abstract][Full Text] [Related]
10. Upregulation of microRNA‑27b contributes to the migration and invasion of gastric cancer cells via the inhibition of sprouty2‑mediated ERK signaling.
Jiang J; Yi B; Qin C; Ding S; Cao W
Mol Med Rep; 2016 Mar; 13(3):2267-72. PubMed ID: 26781754
[TBL] [Abstract][Full Text] [Related]
11. 5-Hydroxymethylcytosine signature in circulating cell-free DNA as a potential diagnostic factor for early-stage colorectal cancer and precancerous adenoma.
Xiao Z; Wu W; Wu C; Li M; Sun F; Zheng L; Liu G; Li X; Yun Z; Tang J; Yu Y; Luo S; Sun W; Feng X; Cheng Q; Tao X; Wu S; Tao J
Mol Oncol; 2021 Jan; 15(1):138-150. PubMed ID: 33107199
[TBL] [Abstract][Full Text] [Related]
12. Enhanced CXCR4 Expression Associates with Increased Gene Body 5-Hydroxymethylcytosine Modification but not Decreased Promoter Methylation in Colorectal Cancer.
Stuckel AJ; Zhang W; Zhang X; Zeng S; Dougherty U; Mustafi R; Zhang Q; Perreand E; Khare T; Joshi T; West-Szymanski DC; Bissonnette M; Khare S
Cancers (Basel); 2020 Feb; 12(3):. PubMed ID: 32110952
[TBL] [Abstract][Full Text] [Related]
13. Altered regulation of the Spry2/Dyrk1A/PP2A triad by homocysteine impairs neural progenitor cell proliferation.
Rabaneda LG; Geribaldi-Doldán N; Murillo-Carretero M; Carrasco M; Martínez-Salas JM; Verástegui C; Castro C
Biochim Biophys Acta; 2016 Dec; 1863(12):3015-3026. PubMed ID: 27686255
[TBL] [Abstract][Full Text] [Related]
14. Van-Gogh-like 2 antagonises the canonical WNT pathway and is methylated in colorectal cancers.
Piazzi G; Selgrad M; Garcia M; Ceccarelli C; Fini L; Bianchi P; Laghi L; D'Angelo L; Paterini P; Malfertheiner P; Chieco P; Boland CR; Bazzoli F; Ricciardiello L
Br J Cancer; 2013 Apr; 108(8):1750-6. PubMed ID: 23579212
[TBL] [Abstract][Full Text] [Related]
15. ROR2 is epigenetically inactivated in the early stages of colorectal neoplasia and is associated with proliferation and migration.
Ma SS; Srivastava S; Llamosas E; Hawkins NJ; Hesson LB; Ward RL; Ford CE
BMC Cancer; 2016 Jul; 16():508. PubMed ID: 27440078
[TBL] [Abstract][Full Text] [Related]
16. Epigenetic profiling and mRNA expression reveal candidate genes as biomarkers for colorectal cancer.
Zhang H; Dong S; Feng J
J Cell Biochem; 2019 Jun; 120(6):10767-10776. PubMed ID: 30672027
[TBL] [Abstract][Full Text] [Related]
17. 5-Hydroxymethylcytosine profiling from genomic and cell-free DNA for colorectal cancers patients.
Gao P; Lin S; Cai M; Zhu Y; Song Y; Sui Y; Lin J; Liu J; Lu X; Zhong Y; Cui Y; Zhou P
J Cell Mol Med; 2019 May; 23(5):3530-3537. PubMed ID: 30912288
[TBL] [Abstract][Full Text] [Related]
18. SPROUTY-2 represses the epithelial phenotype of colon carcinoma cells via upregulation of ZEB1 mediated by ETS1 and miR-200/miR-150.
Barbáchano A; Fernández-Barral A; Pereira F; Segura MF; Ordóñez-Morán P; Carrillo-de Santa Pau E; González-Sancho JM; Hanniford D; Martínez N; Costales-Carrera A; Real FX; Pálmer HG; Rojas JM; Hernando E; Muñoz A
Oncogene; 2016 Jun; 35(23):2991-3003. PubMed ID: 26455323
[TBL] [Abstract][Full Text] [Related]
19. DNA hypermethylation contributes to colorectal cancer metastasis by regulating the binding of CEBPB and TFCP2 to the CPEB1 promoter.
Shao K; Pu W; Zhang J; Guo S; Qian F; Glurich I; Jin Q; Ma Y; Ju S; Zhang Z; Ding W
Clin Epigenetics; 2021 Apr; 13(1):89. PubMed ID: 33892791
[TBL] [Abstract][Full Text] [Related]
20. Epigenetic and transcriptional dysregulation of VWA2 associated with a MYC-driven oncogenic program in colorectal cancer.
González B; Fece de la Cruz F; Samuelsson JK; Alibés A; Alonso S
Sci Rep; 2018 Jul; 8(1):11097. PubMed ID: 30038405
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
